• A40926 Biosynthesis and Dalbavancin Pathway Engineering

  2026-09-28

  Sosio and Donadio’s review connects characterization of the A40926 biosynthetic gene cluster with pathway engineering in its Nonomuraea producer, showing how targeted gene inactivation can generate new glycopeptide derivatives. The work also highlights biosynthetic differences between teicoplanin- and vancomycin-family antibiotics, offering a framework for interpreting A40926 as both a complex natural product and a dalbavancin precursor.

• Tunicamycin: From ER Stress to Translational Insight

  2026-09-27

  Tunicamycin offers researchers a direct way to perturb protein N-glycosylation and examine how ER stress reshapes cellular responses. This article connects its use as an N-glycosylation inhibitor with emerging evidence on QRICH1, HMGB1, and HBV-associated liver fibrosis—while distinguishing experimental opportunity from translational proof.

• 10074-G5 Workflows for c-Myc Cancer Research

  2026-09-26

  Use 10074-G5 to test whether c-Myc/Max signaling helps sustain aggressive cancer-cell phenotypes, including the EMT and motility changes linked to miR-196a in esophageal adenocarcinoma. This guide combines practical dose-finding and assay controls with clear limits on what the existing evidence establishes.

• SIRT1 Links Vascular Activity to Aged Bone Repair

  2026-09-25

  Liu et al. report that SIRT1 supports endothelial activity and osteogenic differentiation in experimental models of skeletal aging, with β-catenin–Wnt signaling implicated as a downstream mediator. Pharmacological SIRT1 activation also improved regeneration in aged femoral and mandibular bone defects, providing a preclinical rationale for studying coordinated vascular and bone-cell responses in repair.

• Cytosine Base Editing: Fidelity Before Translation

  2026-09-25

  Cytosine base editing offers a precise route to targeted nucleotide changes, but editing efficiency alone is not a sufficient translational endpoint. Evidence from mouse embryos shows why editor-specific, genome-wide validation should accompany guide optimization and functional testing. This article connects that evidence to practical research decisions for EZ Cap™ CBEmax mRNA (m1Ψ), while distinguishing published findings from product-specific performance claims.

• 4-Methoxychalcone-1: Research Use and Assay Design

  2026-09-24

  Explore how to evaluate 4-Methoxychalcone-1 in cell-based research without confusing compound identity with pathway evidence. A recent retinal neovascularization study offers a useful model for designing rigorous, multi-endpoint angiogenesis experiments.

• STAT3 as a Translational Control Point in Cancer

  2026-09-24

  Cucurbitacin I (JSI-124) offers a useful way to interrogate STAT3-dependent cancer phenotypes—but translational value depends on proving pathway engagement, separating it from general toxicity, and testing the mechanism in the right biological context. This article outlines a rigorous experimental strategy and considers what emerging human assembloid research can teach about model choice without implying an untested cardiac application.

• CD109 Drives Stemness and Drug Resistance in CRC

  2026-09-23

  A 2026 study identifies a CD109–LRRC8A–AKAP12–PKCα signaling axis that activates STAT3 and supports WNT-associated stemness and chemotherapy resistance in advanced colorectal cancer. Its combination of tumor-expression analyses, cellular perturbations, and mouse metastasis models points to CD109 as a candidate vulnerability, while leaving important questions about mechanism and clinical translation open.

• SW033291: From Target Engagement to Tissue Repair

  2026-09-23

  SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, hematopoiesis, and tissue repair. This article presents an assay-to-translation framework that separates molecular target engagement from context-dependent regenerative phenotypes.

• 15-PGDH Inhibition and Muscle Recovery During Weight Loss

  2026-09-22

  The reference study identifies 15-PGDH inhibition as a strategy to improve muscle stem cell activity, regenerated myofiber growth, and strength recovery during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide improved postinjury muscle quality and force without eliminating the desired reduction in body weight.

• Rational Design of IR-1061 NIR-II Liposomes

  2026-09-22

  This 2021 study shows that IR-1061 fluorescence is governed not only by the dye structure but also by liposome charge, loading level, and molecular confinement. The optimized IR1061-ALP-N3 nanosystem produced high-resolution systemic angiography and maintained vascular fluorescence for more than 16 hours in mice, offering practical design principles for NIR-II imaging formulations.

• Triiodothyronine: Reliable T3 Assay Workflows

  2026-09-21

  This scenario-based guide shows how Triiodothyronine (SKU C6407) can improve experimental control in viability, proliferation, cytotoxicity, and cellular metabolism assays. It covers interpretation of T3-driven metabolic effects, DMSO stock preparation, stability, orthogonal validation, and practical vendor-selection criteria.

• N4-Acetylcytidine as a Control for RNA Assays

  2026-09-21

  N4-Acetylcytidine is more than an RNA-modification standard: it can help researchers separate free-nucleoside metabolism from RNA-bound ac4C biology. This article develops an assay-centered framework based on recent ASCH-domain structural findings, product chemistry, and orthogonal control design.

• Astrocytic GAT-3 in Dentate Gyrus Memory

  2026-09-20

  The reference study shows that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus synaptic transmission and supports contextual fear memory. Its findings distinguish transporter-mediated astrocyte signaling from canonical GABA receptor effects, providing a mechanistic framework for synaptic transmission research and future pharmacological controls.

• NMDA in Excitotoxicity and Retinal Ferroptosis

  2026-09-19

  NMDA provides a controlled receptor-level trigger for excitotoxicity research, calcium influx measurement, and oxidative-stress profiling. Its use in a retinal glaucoma model also enables practical testing of how BMP4-GPX4-associated responses relate to ferroptosis, RGC injury, and stem-cell differentiation.

8680 records 6/579 page Previous Next First page 上5页 678910 下5页 Last page